DGAP-News: MorphoSys AG: Health Canada erteilt Zulassung für Minjuvi(R) (Tafasitamab) in Kombination mit Lenalidomid für die Behandlung von Erwachsenen mit rezidiviertem oder refraktärem diffusem großzelligem B-Zell-Lymphom finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
CSPs).
(a) COVID-19
In response to the COVID-19 pandemic, the federal government
pursued Interim Orders and other policy changes intended to
expedite the development of COVID-19-related products, including
drugs, vaccines, hand sanitizers, disinfectants, personal
protective equipment, and medical devices (see
e.g., here and here). Both the federal and provincial
governments made regulatory changes to secure domestic drug
supplies and mitigate shortages (see
e.g., here and here). Many of these policies were passed on
an interim basis but still remain in effect.
Patent Act, adding a
provision that allowed the Minister of Health to apply for
authorization to make, construct, use, and sell a patented